Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma

BACKGROUND: Patients with N3 stage nasopharyngeal carcinoma (NPC) are at high risk for treatment failure. This study aims to assess the efficacy of maintenance chemotherapy (MC) using S-1 (MC-S1), a novel oral fluoropyrimidine agent, following definitive chemoradiotherapy (CRT) using intensity-modul...

Descripción completa

Detalles Bibliográficos
Autores principales: Zong, Jingfeng, Xu, Hanchuan, Chen, Bijuan, Guo, Qiaojuan, Xu, Yun, Chen, Chuanben, Weng, Youliang, Zheng, Wei, Pan, Jianji, Lin, Shaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806566/
https://www.ncbi.nlm.nih.gov/pubmed/31640719
http://dx.doi.org/10.1186/s13014-019-1387-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806566/
https://www.ncbi.nlm.nih.gov/pubmed/31640719
http://dx.doi.org/10.1186/s13014-019-1387-9

Ejemplares similares